News Medical on MSN4h
Engineering safe and effective vaccinia virus vectors for next-generation vaccinesAnnouncing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against ...
Explore a comprehensive guide to standardizing large scale production and clarification of lentiviral vectors.
Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...
Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
GlobalData on MSN9d
Thermo Fisher continues viral vector withdrawal; lays off 300 employeesThe cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.
AZoLifeSciences on MSN2d
Gene Delivery Systems: Viral vs. Non-Viral VectorsThis article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...
Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been ...
Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.
News Medical on MSN1d
The growing list of human viruses: Are we prepared for the next outbreak?Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...
Prolific Machines, a biotechnology innovator unlocking unprecedented cellular control with light, appoints Christina Perry as CFO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback